---
figid: PMC9271773__fonc-12-829212-g002
figtitle: 'Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy'
organisms:
- Mus musculus
- Cricetulus griseus
- Homo sapiens
- Gallus gallus
- Coxiella burnetii
organisms_ner:
- Mus musculus
- Cricetulus griseus
- Homo sapiens
- Gallus gallus
- Drosophila melanogaster
pmcid: PMC9271773
filename: fonc-12-829212-g002.jpg
figlink: /pmc/articles/PMC9271773/figure/f2/
number: F2
caption: 'The roles of adenylate cyclases in tumorigenesis. After binding to G protein-coupled
  receptors, hormones, neurotransmitters, and a number of other signaling molecules,
  cyclic adenosine 3′,5′-monophosphate (cAMP) is generated from ATP by the action
  of adenylate cyclase and degraded to the 5′-cAMP by the action of cyclic nucleotide
  phosphodiesterase (PDE). cAMP can increase DNA damage via a range of pathways and
  plays an important role in endoskeletal remodeling, cell proliferation, adhesion,
  and EMT. It also regulates the permeability of the mitochondrial outer membrane,
  affecting cell survival, activates the WNT/β-catenin pathway, and regulates the
  processes of cell cycle arrest, apoptosis, survival, and DNA damage. cAMP signaling
  pathways can also protect cancer cells from apoptosis after exposure to radiation
  or chemotherapeutic agents through related pathways. Abbreviations: EGFR, epidermal
  growth factor receptor; tmAC, transmembrane adenylate cyclase; Gs, stimulatory G-protein;
  sAC, soluble adenylate cyclase; ATP, adenosine triphosphate; PDE, phosphodiesterase;
  cAMP, cyclic adenosine phosphate; PKA, protein kinase A; JNK, c-Jun N-terminal kinase;
  Bcl-2, B-cell lymphoma-2; MOM, mitochondrial outer membrane; HDAC8, histone deacetylase
  8; MAPK, mitogen-activated protein kinase; CREB, cAMP response element-binding proteins;
  IAPs, inhibitor of apoptosis proteins; PP2A, protein phosphatase 2A; ATM, the ataxia–telangiectasia–mutated
  protein; Raf-MEK-ERK, Raf/mitogen-activated extracellular signal-regulated kinase/extracellular
  signal-regulated kinase; EPAC, cAMP-EGF-I/II; ERK, extracellular signal-regulated
  kinase; XRCC1, X-ray repair complementing defective repair in Chinese hamster cell
  1; EMT, epithelial-mesenchymal transition; SOCS-3, suppressor of cytokine signaling
  3; C/EBP, CCAAT/enhancer-binding protein.'
papertitle: 'Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy.'
reftext: Rui Guo, et al. Front Oncol. 2022;12:829212.
year: '2022'
doi: 10.3389/fonc.2022.829212
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: adenylate cyclase | cAMP signaling | molecular targeted therapy | chemoresistance
  | signaling pathway 4
automl_pathway: 0.9241502
figid_alias: PMC9271773__F2
figtype: Figure
redirect_from: /figures/PMC9271773__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9271773__fonc-12-829212-g002.html
  '@type': Dataset
  description: 'The roles of adenylate cyclases in tumorigenesis. After binding to
    G protein-coupled receptors, hormones, neurotransmitters, and a number of other
    signaling molecules, cyclic adenosine 3′,5′-monophosphate (cAMP) is generated
    from ATP by the action of adenylate cyclase and degraded to the 5′-cAMP by the
    action of cyclic nucleotide phosphodiesterase (PDE). cAMP can increase DNA damage
    via a range of pathways and plays an important role in endoskeletal remodeling,
    cell proliferation, adhesion, and EMT. It also regulates the permeability of the
    mitochondrial outer membrane, affecting cell survival, activates the WNT/β-catenin
    pathway, and regulates the processes of cell cycle arrest, apoptosis, survival,
    and DNA damage. cAMP signaling pathways can also protect cancer cells from apoptosis
    after exposure to radiation or chemotherapeutic agents through related pathways.
    Abbreviations: EGFR, epidermal growth factor receptor; tmAC, transmembrane adenylate
    cyclase; Gs, stimulatory G-protein; sAC, soluble adenylate cyclase; ATP, adenosine
    triphosphate; PDE, phosphodiesterase; cAMP, cyclic adenosine phosphate; PKA, protein
    kinase A; JNK, c-Jun N-terminal kinase; Bcl-2, B-cell lymphoma-2; MOM, mitochondrial
    outer membrane; HDAC8, histone deacetylase 8; MAPK, mitogen-activated protein
    kinase; CREB, cAMP response element-binding proteins; IAPs, inhibitor of apoptosis
    proteins; PP2A, protein phosphatase 2A; ATM, the ataxia–telangiectasia–mutated
    protein; Raf-MEK-ERK, Raf/mitogen-activated extracellular signal-regulated kinase/extracellular
    signal-regulated kinase; EPAC, cAMP-EGF-I/II; ERK, extracellular signal-regulated
    kinase; XRCC1, X-ray repair complementing defective repair in Chinese hamster
    cell 1; EMT, epithelial-mesenchymal transition; SOCS-3, suppressor of cytokine
    signaling 3; C/EBP, CCAAT/enhancer-binding protein.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Bcl2
  - Pthlh
  - Gpbar1
  - Creb1
  - Ctnnb1
  - Ppp2ca
  - Ppp2r1a
  - Atm
  - Tpm1
  - Cast
  - Polr1g
  - Erc2
  - Tas1r3
  - Adcy10
  - Ephb2
  - Mapk1
  - Tam1
  - Vav2
  - Akt1
  - Ebp
  - Rapgef3
  - Socs3
  - Terf2ip
  - Rap1a
  - Mapk3
  - Xrcc1
  - Nfkb1
  - BCL2
  - PTHLH
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - APRT
  - MFAP1
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - CTNNB1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - ATP8A2
  - PTPA
  - ATM
  - CAST
  - POLR1G
  - ERC2
  - ADCY10
  - EPHB2
  - STIM1
  - VAV2
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - COL1A1
  - COL1A2
  - EBP
  - GLB1
  - SH3D19
  - RAPGEF3
  - RAPGEF4
  - SOCS3
  - RAP1A
  - RABGEF1
  - TERF2IP
  - RAP1B
  - XRCC1
  - NFKB1
  - Debcl
  - dome
  - MKP-4
  - p38b
  - rl
  - Oamb
  - CrebB
  - CrebA
  - Amph
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - arm
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - ATPsynbeta
  - Atpalpha
  - CycE
  - cyc
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - poe
  - wrd
  - wdb
  - mts
  - tws
  - Pp2A-29B
  - tefu
  - cast
  - brp
  - sac
  - moa
  - Erk7
  - aly
  - Rac1
  - Rac2
  - Akt
  - Mtl
  - Act5C
  - Act42A
  - Act57B
  - Act79B
  - Act88F
  - Act87E
  - Col4a1
  - slbo
  - Epac
  - Rap1
  - p38a
  - Dif
  - dl
  - Rel
---
